Gara Jalqabaatti › Histiyosaayitoosis Seli Laangerhaans › Ohio
Qorannoo klinikaalii Histiyosaayitoosis Seli Laangerhaans Ohio keessatti
Qorannoo 3 Histiyosaayitoosis Seli Laangerhaans f Ohio keessatti hirmaatuu jiru.
Takkalaa qorannoo (Ingiliffa)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Rainbow Babies and Childrens Hospital, Cleveland
- Nationwide Children's Hospital, Columbus
- Dayton Children's Hospital, Dayton
Namoota walitti qabaa jiraSadarkaa 2
180 Days – 22 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05828069Mirdametinib in Histiocytic Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06153173Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Nationwide Children's Hospital, Columbus
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 21 · Saalaa hunda · Haaromfame 11-Ful-2025 · NCT02670707Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.